Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Reshmitha Radhakrishnan"'
Publikováno v:
Endocrine Diseases in Pregnancy and the Postpartum Period ISBN: 9781003027577
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1cf7822a0fd705355bab72495a78917
https://doi.org/10.1201/9781003027577-22
https://doi.org/10.1201/9781003027577-22
Publikováno v:
BMJ Case Rep
Radiation recall (RR) is a chemotherapy-induced reaction that leads to inflammation and necrosis in previously irradiated tissue. Gemcitabine is a cytidine analogue that is often used in conjunction with nab-paclitaxel in the treatment of pancreatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc78ddc2c362f20937d650fa91141426
https://europepmc.org/articles/PMC8098950/
https://europepmc.org/articles/PMC8098950/
Autor:
Frances M. Weaver, Jennifer N. Hill, Laura D. Carbone, Brian Le, Reshmitha Radhakrishnan, Marylou Guihan, Michael H. Heggeness, Cara Ray, Wanda Jirau-Rosaly, Mattie Raiford, B. Catharine Craven, Robert L. Harmon, Bella Etingen, Nour Zleik
Publikováno v:
J Spinal Cord Med
Objectives: The primary objective was to review the literature regarding methodologies to assess fracture risk, to prevent and treat osteoporosis and to manage osteoporotic fractures in SCI/D. Study Design: Scoping review. Settings/Participants: Huma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d119cc6937583e0f700427db770a02bb
https://pubmed.ncbi.nlm.nih.gov/29745791
https://pubmed.ncbi.nlm.nih.gov/29745791
Autor:
S. J. Oh, Reshmitha Radhakrishnan, Norris Stanley Nahman, Brian Le, Laura D Carbone, Mufaddal Kheda, Jennifer L. Waller
Publikováno v:
Lupus. 27(1)
Background The incidence of end stage renal disease (ESRD) in patients with systemic lupus erythematosus (SLE) is rising. However, the relationship between osteoporotic fractures and SLE in the setting of ESRD remains uninvestigated. The purpose of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b75c92968736aa57ad972e3240395b39
https://pubmed.ncbi.nlm.nih.gov/28530467
https://pubmed.ncbi.nlm.nih.gov/28530467
Publikováno v:
International journal of clinical and experimental pathology. 7(9)
The HER2 oncogene shows expression or amplification, or both, in approximately 15% to 20% of breast cancers and has been associated with poor prognosis and a response to trastuzumab therapy. HER2 gene status determines the eligibility of breast cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d8bdda8aa16c379b947f869e407875ff
https://pubmed.ncbi.nlm.nih.gov/25337277
https://pubmed.ncbi.nlm.nih.gov/25337277